An impurity found in risperidone
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Risperidone E-oxime

Item No. 22156

Technical Information
Formal Name
3-[2-[4-[(E)-(2,4-difluorophenyl)(hydroxyimino)methyl]-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
CAS Number
691007-09-7
Molecular Formula
C23H28F2N4O2
Formula Weight
Purity
≥98%
A solid
SMILES
O=C1N2C(CCCC2)=NC(C)=C1CCN3CCC(/C(C4=CC=C(F)C=C4F)=N\O)CC3
InChi Code
InChI=1S/C23H28F2N4O2/c1-15-18(23(30)29-10-3-2-4-21(29)26-15)9-13-28-11-7-16(8-12-28)22(27-31)19-6-5-17(24)14-20(19)25/h5-6,14,16,31H,2-4,7-13H2,1H3/b27-22+
InChi Key
BRCINVRBDDVLDW-HPNDGRJYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Risperidone E-oxime is a potential impurity found in commercial preparations of risperidone.1,2 Risperidone (Item No. 13629) is a longer-acting benzisoxazole derivative used for treating schizophrenia, and also the psychotic, affective, or behavioral symptoms associated with other disorders.3,4 This second-generation antipsychotic was designed to antagonize both D2 and 5-HT2A receptors.5,6 It has little effect on cholinergic and β-adrenergic receptors but does affect α2-adrenergic and histamine H1 receptors.5,6

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Bharathi, C., Chary, D.K., Kumar, M.S., et alIdentification, isolation and characterization of potential degradation product in risperidone tablets. J. Pharm. Biomed. Anal. 46(1), 165-169 (2008).

    2. Nejedly, T., Pilarova, P., Kastner, P., et alDevelopment and validation of rapid UHPLC method for determination of risperidone and its impurities in bulk powder and tablets. Int. J. Res. Pharm. Chem. 4(2), 261-266 (2014).

    3. Colpaert, F.C. Discovering risperidone: The LSD model of psychopathology. Nat. Rev. Drug Discov. 2, 315-320 (2003).

    4. Rainer, M.K. Risperidone long-acting injection: A review of its long term safety and efficacy. Neuropsychiatr. Dis. Treat. 4(5), 919-927 (2008).

    5. Edwards, J.G. Risperidone for schizophrenia. BMJ 308(6940), 1311-1312 (1994).

    6. Bymaster, F.P., Calligaro, D.O., Falcone, J.F., et alRadioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14(2), 87-96 (1996).